The company manufactures and sells modified thermoplastic compounds, primarily reinforced polypropylene and engineering plastics, used by automotive and consumer appliance manufacturers to replace metal parts with lightweight, high-performance materials.
The company possesses a narrow moat based on technical switching costs and deep integration with automotive OEMs for safety-critical parts. While ROCE is healthy at 14.1%, the low net margins of 4.2% suggest limited pricing power against large industrial buyers and high sensitivity to raw material costs.
Management has focused on organic capacity expansion at the Chakan facility and R&D investment to localize specialty compounds. While revenue growth is strong, the cash conversion ratio of 0.17 is notably low, indicating significant capital is tied up in working capital rather than being returned to shareholders.
The investment collapsed as the company's abysmal cash conversion of 0.17 proved to be a structural defect rather than a temporary phase, leading to a liquidity crunch despite reported earnings growth. As raw material costs spiked, the company's thin 4.2% net margins evaporated, revealing a total lack of pricing power against dominant automotive OEMs. The heavy reliance on the Chinese parent for related-party transactions eventually led to unfavorable transfer pricing that drained local minority shareholder value, while the lack of domestic data backups and frequent compliance officer turnover foreshadowed a breakdown in corporate governance that triggered a massive de-rating.
RichFakir rates Kingfa Science & Technology (India) Ltd's business quality as mediocre — 52/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Kingfa Science & Technology (India) Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Kingfa Science & Technology (India) Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Kingfa Science & Technology (India) Ltd's fair value is about ₹1,747 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →